Importance of endogenous atrial and brain natriuretic peptides in murine embryonic vascular and organ development

Endocrinology

Volumn 157, Issue 1, 2016, Pages 358-367

  Tokudome, Takeshi ^a   Kishimoto, Ichiro ^a   Shindo, Takayuki ^b   Kawakami, Hayato ^c   Koyama, Teruhide ^b   Otani, Kentaro ^a   Nishimura, Hirohito ^a   Miyazato, Mikiya ^a   Kohno, Masakazu ^d   Nakao, Kazuwa ^e   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYORIN UNIVERSITY   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CONNEXIN 43; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KRUPPEL LIKE FACTOR 2; MESSENGER RNA; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; KLF2 PROTEIN, HUMAN; KLF2 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; NATRIURETIC PEPTIDE RECEPTOR A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLEEDING; BONE DEVELOPMENT; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; EMBRYO; FETUS HYDROPS; GENE EXPRESSION; GENOTYPE; LIVER HEMORRHAGE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NORTHERN BLOTTING; ORGANOGENESIS; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; YOLK SAC; AGONISTS; ANIMAL; CELL CULTURE; CROSS BREEDING; CYTOLOGY; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KNOCKOUT MOUSE; MAMMALIAN EMBRYO; METABOLISM; PATHOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL; VETERINARY;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CROSSES, GENETIC; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROPS FETALIS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NATRIURETIC PEPTIDE, BRAIN; NEOVASCULARIZATION, PHYSIOLOGIC; ORGANOGENESIS; PREGNANCY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; SIGNAL TRANSDUCTION;

EID: 84954480479     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1344     Document Type: Article

References (36)

1. Saito Y, Kishimoto I, Nakao K. Roles of guanylyl cyclase-a signaling in the cardiovascular system. Can J Physiol Pharmacol. 2011;89:551-556.
2. Yamahara K, Itoh H, Chun TH, et al. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA. 2003;100:3404-3409.
3. Park K, Itoh H, Yamahara K, et al. Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases. Endocrinology. 2008;149:483-491.
4. Tokudome T, Kishimoto I, Yamahara K, et al. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol. 2009;29:1516-1521.
5. Lopez MJ, Wong SK, Kishimoto I, et al. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 1995;378:65-68.
6. Thomsen JK, Storm TL, Thamsborg G, De Nully M, Bødker B, Skouby SO. Increased concentration of circulating atrial natriuretic peptide during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1988;27:197-201.
7. Itoh H, Sagawa N, Hasegawa M, et al. Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. J Clin Endocrinol Metab. 1993;76:907-911.
8. Graham CH, Watson JD, Blumenfeld AJ, Pang SC. Expression of atrial natriuretic peptide by third-trimester placental cytotrophoblasts in women. Biol Reprod. 1996;54:834-840.
9. Fukuhara S, Sako K, Minami T, et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin 1. Nat Cell Biol. 2008;10:513-526.
10. Tokudome T, Horio T, Yoshihara F, et al. Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism. Endocrinology. 2002;143:3515-3521.
11. Nojiri T, Hosoda H, Tokudome T, et al. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells. Proc Natl Acad Sci USA. 2015;112:4086-4091.
12. Atkins GB, Jain MK. Role of Krüppel-like transcription factors in endothelial biology. Circ Res. 2007;100:1686-1695.
13. Fraisl P, Mazzone M, Schmidt T, Carmeliet P. Regulation of angiogenesis by oxygen and metabolism. Dev Cell. 2009;16:167-179.
14. Walther T, Stepan H. C-type natriuretic peptide in reproduction, pregnancy, and fetal development. J Endocrinol. 2004;180:17-22.
15. Scott NJ, Ellmers LJ, Lainchbury JG, et al. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim Biophys Acta. 2009;1792(12):1175-1184.
16. Cameron VA, Aitken GD, Ellmers LJ, Kennedy MA, Espiner EA. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology. 1996;137:817-824.
17. Cameron VA, Ellmers LJ. Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology. 2003;144:2191-2194.
18. Johnson D, Tetzke T, Cheung C. Gene expression of atrial natriuretic factor in ovine fetal heart during development. J Soc Gynecol Invest. 1994;1:14-18.
19. Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca (2+)-ATPase gene. Circ Res. 1992;71:9-17.
20. Gardner DG, Hedges B, Wu J, La Pointe MC, Deschepper CF. Expression of the atrial natriuretic peptide gene in human fetal heart. J Clin Endocrinol Metab. 1989;69:729-737.
21. Tokudome T, Horio T, Kishimoto I, et al. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation. 2005;111:3095-3104.
22. Tokudome T, Kishimoto I, Horio T, et al. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation. 2008;117:2329-2339.
23. Hatjis CG, Grogan DM. Atrial natriuretic peptide receptors in normal human placentas. Am J Obstet Gynecol. 1988;159:587-591.
24. Yamaji T, Hirai N, Ishibashi M, Takaku F, Yanaihara T, Nakayama T. Atrial natriuretic peptide in umbilical cord blood: evidence for a circulating hormone inhumanfetus. J Clin Endocrinol Metab. 1986;63:1414-1417.
25. Templeton AG, Kingdom JC, Macmillan JB, McGrath JC, Whittle MJ. Atrial natriuretic peptide counteracts the vasoconstrictor effects of 5-hydroxytryptamine, U46619 and endothelin-1 in the human umbilical artery. Placenta. 1994;15:715-720.
26. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci USA. 2000;97:8386-8391.
27. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86:1690-1697.
28. Kuhn M, Völker K, Schwarz K, et al. The natriuretic peptide-guanylyl cyclase-a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest. 2009;119:2019-2130.
29. Lee JS, Yu Q, Shin JT, et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell. 2006;11:845-857.
30. Suga S, Nakao K, Itoh H, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor κ. Possible existence of "vascular natriuretic peptide system." J Clin Invest. 1992;90:1145-1149.
31. Dekker RJ, Van Soest S, Fontijn RD, et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). Blood. 2002;100:1689-1698.
32. Sako K, Fukuhara S, Minami T, et al. Angiopoietin 1 induces Kruppellike factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J Biol Chem. 2009;284:5592-5601.
33. Kim J. Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension. Mol Cells. 2014;37:196-201.
34. Vaidya D, Tamaddon HS, Lo CW, et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ Res. 2001;88(11):1196-1202.
35. Pfeifer A, Klatt P, Massberg S, et al. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 1998;17:3045-3051.
36. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27(1):47-72.